Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older

Completed · Phase 3

Conditions studied: Influenza

In brief

Evaluate safety and immunogenicity of three influenza vaccines in adults 18 years of age and above.

Key facts

Study ID
NCT01992094
Run by
Novartis Vaccines
People needed
2680
Starts
2013-11-01
Expected to finish
2014-07-01
Last updated by the study team
2015-12-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.